Metformina Mylan Generics

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformina Mylan Generics (Metformin Hydrochloride)

Q: What is Metformina Mylan Generics used for?

Metformina Mylan Generics contains metformin hydrochloride and is prescribed to improve blood‑glucose control in adults with type 2 diabetes mellitus. It may also be used in certain cases of impaired glucose tolerance to delay progression to diabetes.

Q: How does metformin work in the body?

Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, reducing intestinal glucose absorption, and increasing peripheral insulin sensitivity through activation of the AMP‑activated protein kinase (AMPK) pathway.

Q: What is the usual dose of Metformina Mylan Generics?

The dosage of Metformina Mylan Generics is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions exactly.

Q: Is Metformina Mylan Generics safe during pregnancy or breastfeeding?

Safety in pregnancy and lactation has not been fully established. Healthcare providers should evaluate the potential benefits and risks before prescribing metformin to pregnant or nursing women.

Q: How do I order Metformina Mylan Generics from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformina Mylan Generics compare with other antidiabetic drugs?

Metformin is a first‑line biguanide that improves insulin sensitivity without causing weight gain, unlike some sulfonylureas or insulin. It has a well‑documented safety profile and is often combined with other agents when additional glucose lowering is needed.

Q: What are the storage requirements for Metformina Mylan Generics?

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and keep out of reach of children.

Q: How is Metformina Mylan Generics administered?

Metformina Mylan Generics is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformina Mylan Generics?

The most serious potential adverse effect is lactic acidosis, a rare but life‑threatening condition. Patients with severe renal impairment, hepatic disease, or excessive alcohol intake are at higher risk and should be monitored closely.

Q: Who should not use Metformina Mylan Generics?

Metformina Mylan Generics is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, or acute or chronic metabolic acidosis, including diabetic ketoacidosis.

Metformin hydrochloride, the active ingredient in Metformina Mylan Generics, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.
GNH India supplies Metformina Mylan Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformina Mylan Generics, a biguanide antidiabetic, is used to manage disorders of glucose metabolism.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels.
Impaired glucose tolerance: reduces the risk of progression to type 2 diabetes.
Prediabetes (impaired fasting glucose): helps achieve glycaemic targets and delay disease onset.

How It Works

Metformin hydrochloride reduces hepatic gluconeogenesis, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). These actions collectively lower circulating glucose without stimulating insulin secretion.

Side Effects

Metformina Mylan Generics may cause a range of adverse reactions.

Common Side Effects

Nausea: mild to moderate gastrointestinal upset.
Diarrhea: increased stool frequency, often transient.
Abdominal discomfort: cramping or bloating.
Metallic taste: temporary alteration of taste perception.
Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening metabolic disturbance.
Severe hypoglycaemia: usually when combined with insulin or secretagogues.
Hepatotoxicity: abnormal liver function tests in susceptible individuals.
Skin reactions: rash or hypersensitivity requiring medical attention.

Precautions & Warnings

Before initiating Metformina Mylan Generics, consider the following safety measures.

Renal function assessment: avoid use if eGFR <30 mL/min/1.73 m².
Hepatic disease monitoring: use with caution in liver impairment.
Cardiovascular status: evaluate in patients with heart failure.
Alcohol consumption: limit intake to reduce lactic acidosis risk.
Pregnancy and lactation: discuss risks with a healthcare professional.
Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Avoid Interactions

Metformina Mylan Generics can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis.
Cimetidine: can increase metformin plasma concentrations.
Certain antiretrovirals (e.g., didanosine): heightened risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemia symptoms.
Diuretics: can affect renal clearance of metformin.
ACE inhibitors/ARBs: monitor renal function and potassium levels.

Frequently Asked Questions

Metformina Mylan Generics contains metformin hydrochloride and is prescribed to improve blood‑glucose control in adults with type 2 diabetes mellitus. It may also be used in certain cases of impaired glucose tolerance to delay progression to diabetes.

Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, reducing intestinal glucose absorption, and increasing peripheral insulin sensitivity through activation of the AMP‑activated protein kinase (AMPK) pathway.

The dosage of Metformina Mylan Generics is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions exactly.

Safety in pregnancy and lactation has not been fully established. Healthcare providers should evaluate the potential benefits and risks before prescribing metformin to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line biguanide that improves insulin sensitivity without causing weight gain, unlike some sulfonylureas or insulin. It has a well‑documented safety profile and is often combined with other agents when additional glucose lowering is needed.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and keep out of reach of children.

Metformina Mylan Generics is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious potential adverse effect is lactic acidosis, a rare but life‑threatening condition. Patients with severe renal impairment, hepatic disease, or excessive alcohol intake are at higher risk and should be monitored closely.

Metformina Mylan Generics is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, or acute or chronic metabolic acidosis, including diabetic ketoacidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.